|
|
Volumn 4, Issue 5, 2014, Pages OF8-
|
|
Idelalisib has activity in mantle cell lymphoma
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IDELALISIB;
PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE;
PURINE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
ANTAGONISTS AND INHIBITORS;
DOSE RESPONSE;
HUMAN;
LYMPHOMA, MANTLE-CELL;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL (TOPIC);
ANTINEOPLASTIC AGENTS;
CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE;
CLINICAL TRIALS, PHASE I AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
LYMPHOMA, MANTLE-CELL;
PURINES;
QUINAZOLINONES;
|
|
EID: 84953342500
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-RW2014-072 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|